Cognitive Disorder Clinical Trials in Beijing
4 recruitingBeijing, China
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients
Postoperative Neurocognitive DisorderSurgeryPostoperative Delirium
Xuanwu Hospital, Beijing10,000 enrolled1 locationNCT06423547
Recruiting
Correlation Analysis of POD and pNCD in Elderly Spinal Surgery Patients
Spinal surgeryPostoperative Neurocognitive DisorderPostoperative Delirium
Xuanwu Hospital, Beijing165 enrolled1 locationNCT06466083
Recruiting
Correlation Analysis of POD and pNCD in Elderly Patients With Gastrointestinal Neoplasms
Postoperative Neurocognitive DisorderPostoperative Deliriumgastrointestinal surgery
Xuanwu Hospital, Beijing165 enrolled1 locationNCT06466096